GLP 4-week cynomolgus monkey study, weekly IV (50 or 300 mg/kg) or IM (300 mg), 5 doses, with recovery period
“In the 4-week toxicity study with a 25-week recovery period once weekly i.v. or i.m. administration (5 doses total) of nirsevimab of 0, 300 mg/kg/week i.v. or 0 and 300 mg/kg/week i.m (6 monkeys/sex/group) or 50 mg/kg/week i.v.”